Skip to main content
Karolinska Development logo

Karolinska Development — Investor Relations & Filings

Ticker · KDEV ISIN · SE0002190926 LEI · 54930011ZA52NKO5W681 ST Financial and insurance activities
Open in API
Filings indexed 761 across all filing types
Latest filing 2015-01-16 Capital/Financing Update
Country SE Sweden
Listing ST KDEV

About Karolinska Development

https://www.karolinskadevelopment.com/en

Karolinska Development is an investment company specializing in the life sciences sector. It identifies, finances, and supports the creation and growth of companies developing innovative medical technologies and pharmaceuticals. The firm manages a diversified portfolio of biotechnology and medtech ventures, often originating from academic research, with the goal of developing ground-breaking treatments for severe diseases. Karolinska Development leverages its team's expertise in research, development, and commercialization to guide its portfolio companies, providing both capital and strategic support to advance innovations toward the market.

Recent filings

Filing Released Lang Actions
Uppdatering avseende Karolinska Developments konvertibelemission
Capital/Financing Update Classification · 1% confidence The document is a press release dated January 16, 2015, titled "Uppdatering avseende Karolinska Developments konvertibelemission" (Update regarding Karolinska Development's convertible bond issue). It details the results of a rights issue of convertible bonds, including subscription percentages, amounts raised, and delays in payment from a specific investor (CP Group). It also mentions the extension of the subscription period. This content directly relates to financing activities, capital structure changes, and the issuance of new securities (convertible bonds). This aligns perfectly with the definition of 'Capital/Financing Update' (CAP). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it concerns a specific corporate finance event.
2015-01-16 Swedish
Karolinska Development offentliggör utfallet i företrädesemissionen av konvertibler
Capital/Financing Update Classification · 1% confidence The document is a press release dated December 30, 2014, announcing the outcome of a rights issue of convertible bonds ('företrädesemissionen av konvertibler'). It details the subscription rate, the total capital raised (preliminary SEK 347.9 million), the terms of the convertible loans, conversion details, and the expected listing timeline for the new instruments (BTUs and convertibles). This content directly relates to fundraising, capital structure changes, and the issuance of new securities. This aligns perfectly with the definition for 'Capital/Financing Update' (CAP). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it concerns a specific financing event.
2014-12-30 Swedish
Karolinska Development announces outcome of the rights issue of convertibles
Capital/Financing Update Classification · 1% confidence The document is titled "Karolinska Development announces outcome of the rights issue of convertibles" and details the preliminary subscription results (77%) and proceeds (SEK 347.9 million) from a rights issue of convertibles, including a directed issue to CP Group. This content directly relates to fundraising, financing activities, and changes in the capital structure (issuance of convertible loans and potential dilution). This aligns perfectly with the definition of 'Capital/Financing Update' (CAP). It is not an Annual Report (10-K), an Earnings Release (ER), or a general Regulatory Filing (RNS), as it concerns a specific corporate finance action.
2014-12-30 English
Major Shareholding Notification 2014
Major Shareholding Notification Classification · 1% confidence The document details a change in shareholding for Sino Biopharmaceutical Ltd in Karolinska Development AB. It explicitly mentions 'Reason for major shareholding notification' and provides 'Before the transaction' and 'After the transaction' details regarding the quantity and percentage of shares and voting rights. This structure perfectly matches the definition of a Major Shareholding Notification, which corresponds to the filing code MRQ.
2014-12-15 English
Purchase of own shares to cover social security fees related to incentive program
Transaction in Own Shares Classification · 1% confidence The document explicitly details the Board of Directors' decision to 'purchase a maximum of 136,000 shares of Series B' to cover social security fees related to an incentive program. This action, the buying back of the company's own stock, directly corresponds to the definition of 'Transaction in Own Shares'. The filing type code for this activity is POS.
2014-12-08 English
Återköp av egna aktier för att täcka sociala avgifter kopplade till incitamentsprogram
Transaction in Own Shares Classification · 1% confidence The document text is a formal announcement dated December 8, 2014, regarding the Board of Directors' decision to repurchase up to 136,000 series B shares. The purpose explicitly stated is to cover social fees linked to an incentive program (PSP 2014 II). The key Swedish phrase is "Återköp av egna aktier" (Repurchase of own shares). This directly corresponds to the definition of 'Transaction in Own Shares' (POS), which covers share repurchases. The document length (2128 chars) is short, but it contains the full decision and details, not just an announcement that a report is attached. Therefore, it is classified as the specific transaction announcement rather than a general RPA or RNS.
2014-12-08 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.